Private equity firm Sycamore Partners will split the company into three units separating its US and UK retail pharmacies and its healthcare business if a privatisation bid is successful, the Financial Times reports. 原文链接：Read More 文章导航 Bath & Body Works Forecasts Tepid Annual Results on Tariffs, Spending Concerns Uoma Beauty Founder Sues the Brand’s New Owners